Clinical Trial Update: BFPET for Regional Myocardial Perfusion Imaging [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for BFPET in regional myocardial perfusion imaging for coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• BFPET

Snippet

Sponsor: Fluoropharma, Inc. | Conditions: Coronary Artery Disease | Phase 2 | Status: UNKNOWN